Polymer materials as promoters/inhibitors of amyloid fibril formation

被引:16
|
作者
Holubova, Monika [1 ,2 ]
Stepanek, Petr [1 ]
Hruby, Martin [1 ]
机构
[1] Acad Sci Czech Republ, Inst Macromol Chem, Heyrovsky Sq 2, Prague 16206 6, Czech Republic
[2] Charles Univ Prague, Fac Sci, Dept Phys & Macromol Chem, Albertov 6, Prague 12800 2, Czech Republic
关键词
Amyloidosis; Amyloid fibrils; Polymer; Dendrimers; Polysaccharides; CHITIN-LIKE POLYSACCHARIDES; IRON-OXIDE NANOPARTICLES; B-PEG NANOPARTICLES; ALPHA-SYNUCLEIN; EXTRACELLULAR-MATRIX; PAMAM DENDRIMERS; IN-VITRO; BETA; AGGREGATION; ALZHEIMERS;
D O I
10.1007/s00396-020-04710-8
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
Polymers are omnipresent materials that are widely used in medicine, e.g., as construction materials for medical devices or as polymer nanoparticle drug delivery systems. Therefore, their possible effects on biomolecules, such as lipids, proteins, and other molecules, present in the human body must be examined. This review addresses the effects of polymer materials (such as dendrimers, polysaccharides) on the process of amyloid fibril formation. Amyloidoses are very serious diseases that are characterized by amyloid deposition in various organs and tissues, causing their dysfunction. The treatment of amyloidoses, such as Alzheimer's disease (AD), using polymer materials is a challenge. Studies aiming to elucidate the effects of polymers on the process of amyloid fibril formation are therefore also of key importance for understanding the process of amyloid fibril formation and amyloidoses in general.
引用
收藏
页码:343 / 362
页数:20
相关论文
共 50 条
  • [1] Polymer materials as promoters/inhibitors of amyloid fibril formation
    Monika Holubová
    Petr Štěpánek
    Martin Hrubý
    Colloid and Polymer Science, 2021, 299 : 343 - 362
  • [2] Zwitterionic detergent promoters of in vitro β-amyloid fibril formation
    McLaughlin, RW
    Kong, XQ
    Wu, XF
    Stea, D
    Lavoie, L
    Sarazin, P
    Vali, H
    Chalifour, RJ
    Gervais, F
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2001, 8 : 145 - 145
  • [3] Screening for pharmacologic inhibitors of amyloid fibril formation
    LeVine, H
    Scholten, JD
    AMYLOID, PRIONS, AND OTHER PROTEIN AGGREGATES, 1999, 309 : 467 - 476
  • [4] Hairpin peptide inhibitors of amyloid fibril formation
    Huggins, Kelley
    Andersen, Niels
    JOURNAL OF PEPTIDE SCIENCE, 2008, 14 (08) : 107 - 107
  • [5] Amyloid fibril formation in microwell plates for screening of inhibitors
    Lin, YM
    Raffen, R
    Zhou, YS
    Cassidy, CS
    Flavin, MT
    Stevens, FJ
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2001, 8 (03): : 182 - 193
  • [6] Bisaryloxime ethers as potent inhibitors of transthyretin amyloid fibril formation
    Johnson, SM
    Petrassi, HM
    Palaninathan, SK
    Mohamedmohaideen, NN
    Purkey, HE
    Nichols, C
    Chiang, KP
    Walkup, T
    Sacchettini, JC
    Sharpless, KB
    Kelly, JW
    JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (05) : 1576 - 1587
  • [7] AMYLOID FIBRIL FORMATION
    COLACO, CALS
    HARRINGTON, CR
    BIO-TECHNOLOGY, 1994, 12 (09): : 848 - 849
  • [8] Small-molecule inhibitors of islet amyloid polypeptide fibril formation
    Mishra, Rajesh
    Bulic, Bruno
    Sellin, Daniel
    Jha, Suman
    Waldmann, Herbert
    Winter, Roland
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2008, 47 (25) : 4679 - 4682
  • [9] Flavone Derivatives as Inhibitors of Insulin Amyloid-Like Fibril Formation
    Malisauskas, Ricardas
    Botyriute, Akvile
    Cannon, Jonathan G.
    Smirnovas, Vytautas
    PLOS ONE, 2015, 10 (03):
  • [10] Flavone Derivatives As Inhibitors Of Insulin Amyloid-Like Fibril Formation
    Malisauskas, Ricardas
    Botyriute, Akvile
    Smirnovas, Vytautas
    PROTEIN SCIENCE, 2014, 23 : 263 - 263